
Raberock D 30mg/20mg Capsule SR
Marketer
Orama Life Sciences Private Limited
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Raberock D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with the combined medication, GastroMend 30mg/20mg Sustained-Release Capsules. This formulation alleviates acidity symptoms such as heartburn, abdominal pain, and discomfort by neutralizing stomach acid and facilitating gas expulsion. GastroMend 30mg/20mg SR Capsules should be taken on an empty stomach, following your doctor's prescribed dosage and regimen. Treatment duration depends on individual response and condition severity. Premature discontinuation may lead to symptom recurrence and condition worsening. Inform your physician of all other medications you are currently using, as interactions may occur. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects promptly to your doctor. Drowsiness and dizziness are possible; avoid driving or activities requiring concentration until the medication's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment efficacy. Prior to initiating treatment, disclose any kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.
Primary Ingredients of Raberock D 30mg/20mg Capsule SR
No text was provided. Therefore, no rephrased text can be given.
Uses of Raberock D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Raberock D 30mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Raberock D 30mg/20mg SR Capsules. Ingest the capsules whole; do not crush, chew, or break them. Administer on an empty stomach.
Common Side effects of Raberock D 30mg/20mg Capsule SR:
- Pharyngitis
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Insomnia (difficulty in sleeping)
- Nausea
- Constipation
- Flatulence
- Nasal congestion (stuffy nose)
- Fundic gland polyps
- Back pain
How to use Raberock D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire capsule without chewing, crushing, or breaking it. Raberock D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
How Raberock D 30mg/20mg Capsule SR works:
Raberock D, a sustained-release capsule containing 30mg Domperidone and 20mg Rabeprazole, offers dual-action relief. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid production, thereby alleviating acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Raberock D 30mg/20mg SR Capsules should be approached with care. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Raberock D 30mg/20mg sustained-release capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Raberock D 30mg/20mg capsule is likely unsuitable for use while breastfeeding. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving may be impaired by Raberock D 30mg/20mg SR Capsules, which can cause drowsiness, dizziness, and visual disturbances. Refrain from operating a vehicle if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Raberock D 30mg/20mg sustained-release capsules. Dosage modification of Raberock D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is recommended.
LiverCAUTION
Exercise caution when prescribing Raberock D 30mg/20mg SR capsules to patients with liver impairment; dosage modification may be necessary. Consult a physician before administering. Raberock D 30mg/20mg SR capsules are contraindicated in patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Raberock D 30mg/20mg Capsule SR :
Should you forget to take a Raberock D 30mg/20mg sustained-release capsule, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Raberock D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
